SnowWorld N.V. — M&A Activity 2007

Oct 30, 2007

P R E S S R E L E A S E

Lelystad, 29 October 2007

EGM Fornix approves sale Trade Division to Mosadex

Fornix BioSciences N.V. announces that during today's Extraordinary General Meeting of Shareholders (EGM) the proposed sale of the division Dr. Fisher Farma B.V. was approved unanimously.

The transaction remains subject to the approval of the Dutch Competition Authority (Nederlandse Mededingingsautoriteit) and is expected to ultimately close before the end of this year.

For Further information: Fornix BioSciences N.V.

C.L. Bergman CEO Tel. +31(0)320 26 77 99 (during business hours) http://www.fornix.nl

E N D O F P R E S S R E L E A S E

Profile of Fornix BioSciences N.V.

Fornix BioSciences N.V. is a listed company (Euronext Amsterdam: AFORBI) which focuses on the development and sale of diagnostic and therapeutic allergen products, the distribution of medical aids and medical and nursing consumables and the distribution of patented drugs within the EU. Fornix BioSciences has facilities in Lelystad and Beuningen in the Netherlands and Hamburg in Germany. The company currently employs 200 people and has large customer base in the Netherlands and thirteen other European countries.

The activities are carried on by three divisions, which in turn are made up of operating companies.

The Allergy Division, the most profitable division, consists of Artu Biologicals Europe and, since 1 June 2007, Artu Biologicals Deutschland. It specialises in the development, production and sale of a broad range of patient-friendly immunotherapeutic products under several brand names, including Oralgen® and Igevac®, used to treat allergies caused by agents such as grass and tree pollen and house-dust mites. The development of these products is supported by high-quality R&D and pan-European clinical studies of effectivity.

The Medical Aids Division, consisting of Laprolan/ComforMed in Beuningen, specialises in the marketing, sale and distribution of an extensive range of medical aids and medical and nursing consumables.

The Trading Division, consisting of Dr. Fisher Farma, specialises in purchasing, import, marketing, export, sale and distribution of a wide range of patented drugs to pharmacists and pharmaceutical wholesalers in the Netherlands and thirteen other EU countries.